GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's disease.
about
GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson's diseaseProtective effect of tetrahydroxystilbene glucoside on 6-OHDA-induced apoptosis in PC12 cells through the ROS-NO pathway.Inflammatory cells and cytokines in the olfactory bulb of a rat model of neuroinflammation; insights into neurodegeneration?GDNF therapy for Parkinson's disease.Targeting the progression of Parkinson's disease.Current challenges for the advancement of neural stem cell biology and transplantation research.Immunohistochemical Analysis of GDNF and Its Cognate Receptor GFRα-1 Protein Expression in Vitiliginous Skin Lesions.Lenti-GDNF gene therapy protects against Alzheimer's disease-like neuropathology in 3xTg-AD mice and MC65 cells.Nifedipine and nimodipine protect dopaminergic substantia nigra neurons against axotomy-induced cell death in rat vibrosections via modulating inflammatory responses.Neuroprotective effects of GDNF-expressing human amniotic fluid cells.Effects of glial cell line-derived neurotrophic factor on microRNA expression in a 6-hydroxydopamine-injured dopaminergic cell line.GDNF contributes to oestrogen-mediated protection of midbrain dopaminergic neurones.Mesenchymal stromal SB623 cell implantation mitigates nigrostriatal dopaminergic damage in a mouse model of Parkinson's disease.Protective effects of Lycium barbarum polysaccharide on 6-OHDA-induced apoptosis in PC12 cells through the ROS-NO pathway.Neuroprotective Surgical Strategies in Parkinson's Disease: Role of Preclinical Data.Are Temporal Differences in GDNF and NOS Isoform Induction Contributors to Neurodegeneration? A Fluorescence Microscopy-Based Study.Are Temporal Differences in GDNF and NOS Isoform Induction Contributors to Neurodegeneration? A Fluorescence Microscopy-Based Study.
P2860
Q28088320-DDB4C11F-8112-40F5-98A8-2E8762F12C25Q31038097-AA0DBEB1-E798-4497-926A-CFABFF708A44Q37003565-5D5558E1-A580-4A50-B9D2-0A2315E15B4BQ37203371-F32082B2-D57B-4B44-AB2A-F99E4D584B6FQ37299619-9B7F06CA-B345-46CF-A27D-5DFA971B254DQ37871429-1242B634-CBAC-401E-A7C7-094A7CA66745Q38838204-612FCC20-1D23-4EF3-9088-B734658A808AQ38966488-DC98EB97-7F0F-48FB-B4AA-62FAAF44A637Q38974102-55FCA3E2-5AD4-40F7-B17C-008E31DA8814Q39035207-F84B75A7-BBB0-4F24-A0E3-6EB6C94D0361Q39138879-71977435-C61D-4113-AEC1-5C64CC0E4436Q39336234-7D69765B-0B8E-4DA5-9E27-E2DFC0CF64DCQ40461839-AB6E7EB8-27FA-44D6-9BED-142DCC9EB486Q41641059-D076D8B4-5F67-4E56-A851-4C39AC7F0E5FQ44266420-5B01A746-59AA-4C50-ACD3-84BDE7667A81Q48501539-6D7DB98C-515D-4A5F-A823-EB273CD5AB29Q54913358-5321810F-6659-451C-AD2B-82583E84923F
P2860
GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's disease.
@en
type
label
GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's disease.
@en
prefLabel
GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's disease.
@en
P2860
P1433
P1476
GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's disease.
@en
P2093
Michael P Smith
Wayne A Cass
P2860
P304
P356
10.1016/J.NEULET.2006.11.017
P407
P577
2006-11-27T00:00:00Z